Physician profile
Ankur V Gupta
NPI 1396990560
$21,430.08
in general payments reported to CMS, 2019-2025
26 companies · $3,470 in 2025
The $3,470 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $130 · 2021: $547 · 2022: $3,278 · 2023: $13K · 2024: $450 · 2025: $3,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,900 · Travel and Lodging: $4,356 · Food and Beverage: $3,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,900.00 |
| Travel and Lodging | $4,355.61 |
| Food and Beverage | $3,055.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $10,265.62 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $4,208.25 | 2021-2025 | Linq II, Advisa Dr Mri Surescan, Adapta |
| Abbott Laboratories | $3,142.60 | 2019-2025 | Triclip, Coroflow, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $1,942.25 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $701.24 | 2022-2023 | Versacross Access Solution, Watchman Flx |
| Abiomed | $229.86 | 2022-2025 | Impella |
| Cathworks, INC. | $219.77 | 2022 | |
| Novartis Pharmaceuticals Corporation | $136.65 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.79 | 2021-2025 | Lifevest |
| Philips North America LLC | $75.97 | 2021-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Regeneron Healthcare Solutions, INC. | $66.40 | 2025 | Eylea Hd |
| Alnylam Pharmaceuticals INC. | $44.26 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.98 | 2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $25.28 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $24.87 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $23.73 | 2021 | |
| Pfizer INC. | $23.70 | 2025 | |
| Apellis Pharmaceuticals, INC. | $21.49 | 2024 | Syfovre |
| Integra Lifesciences Corporation | $21.00 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Irhythm Technologies, INC. | $20.28 | 2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $20.13 | 2024 | Nexletol |
| Inari Medical, INC. | $19.99 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Siemens Medical Solutions USA, INC. | $16.91 | 2021 | |
| Bsn Medical INC | $14.96 | 2025 | |
| Novo Nordisk INC | $13.70 | 2023 | |
| Amgen INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.